RESUMO
This brief review is focused on the events surrounding the initial discovery of a new viral hemorrhagic fever in 1969 and the subsequent 10-15 years during which a substantial understanding of the disease was gained. In 1969, a series of sequential life-threating or fatal infections occurred among health care workers in Nigeria and the laboratory scientist who isolated and characterized the causative agent. The agent, Lassa virus was named after the geographical location of the first recognized human case. The new virus was shown to be related to lymphocytic choriomeningitis and to previously unclassified neotropical viruses, including Argentine and Bolivian hemorrhagic fevers, and a new taxonomic grouping, the Arenaviruses, was proposed. In 1970-72, three further epidemics occurred in Nigeria, Liberia and Sierra Leone, the first two involved nosocomial transmission, and the third was a community-based outbreak, during which the rodent reservoir host was identified. In 1976, a long-term research project commenced in Sierra Leone, which produced a rich body of data from prospectively designed studies on the clinical features, transmission, and treatment of the disease.
Assuntos
Febre Lassa , Vírus Lassa , Animais , Anticorpos Antivirais , Arenavirus/genética , Infecção Hospitalar , Surtos de Doenças , Variação Genética , História do Século XX , História do Século XXI , Humanos , Febre Lassa/história , Febre Lassa/fisiopatologia , Febre Lassa/terapia , Febre Lassa/transmissão , Vírus Lassa/genética , Vírus Lassa/patogenicidade , Nigéria , Filogenia , Roedores/virologia , Serra Leoa , Vacinação , ZoonosesRESUMO
Lassa fever (LF) is endemic to Nigeria, where the disease causes substantial rates of illness and death. In this article, we report an analysis of the epidemiologic and clinical aspects of the LF outbreak that occurred in Nigeria during January 1-May 6, 2018. A total of 1,893 cases were reported; 423 were laboratory-confirmed cases, among which 106 deaths were recorded (case-fatality rate 25.1%). Among all confirmed cases, 37 occurred in healthcare workers. The secondary attack rate among 5,001 contacts was 0.56%. Most (80.6%) confirmed cases were reported from 3 states (Edo, Ondo, and Ebonyi). Fatal outcomes were significantly associated with being elderly; no administration of ribavirin; and the presence of a cough, hemorrhaging, and unconsciousness. The findings in this study should lead to further LF research and provide guidance to those preparing to respond to future outbreaks.
Assuntos
Surtos de Doenças , Febre Lassa/diagnóstico , Febre Lassa/epidemiologia , Vírus Lassa , Adolescente , Adulto , Idoso , Criança , Pré-Escolar , Feminino , Geografia Médica , História do Século XXI , Humanos , Lactente , Recém-Nascido , Febre Lassa/história , Febre Lassa/virologia , Masculino , Pessoa de Meia-Idade , Mortalidade , Nigéria/epidemiologia , Razão de Chances , Prevalência , Vigilância em Saúde Pública , Estações do Ano , Avaliação de Sintomas , Adulto JovemRESUMO
We reviewed data pertaining to the massive wave of Lassa fever cases that occurred in Nigeria in 2018. No new virus strains were detected, but in 2018, the outbreak response was intensified, additional diagnostic support was available, and surveillance sensitivity increased. These factors probably contributed to the high case count.
Assuntos
Surtos de Doenças , Febre Lassa/epidemiologia , Animais , História do Século XXI , Humanos , Incidência , Febre Lassa/diagnóstico , Febre Lassa/história , Febre Lassa/virologia , Vírus Lassa/classificação , Vírus Lassa/genética , Vírus Lassa/isolamento & purificação , Nigéria/epidemiologia , Vigilância em Saúde Pública , Estações do AnoRESUMO
Lassa virus is a rodentborne arenavirus responsible for human cases of Lassa fever, a viral hemorrhagic fever, in West Africa and in travelers arriving to non-Lassa-endemic countries from West Africa. We describe a retrospective review performed through literature search of clinical and epidemiologic characteristics of all imported Lassa fever cases worldwide during 1969-2016. Our findings demonstrate that approximately half of imported cases had distinctive clinical features (defined as fever and >1 of the following: pharyngitis, sore throat, tonsillitis, conjunctivitis, oropharyngeal ulcers, or proteinuria). Delays in clinical suspicion of this diagnosis were common. In addition, no secondary transmission of Lassa fever to contacts of patients with low-risk exposures occurred, and infection of high-risk contacts was rare. Future public health investigations of such cases should focus on timely recognition of distinctive clinical features, earlier treatment of patients, and targeted public health responses focused on high-risk contacts.
Assuntos
Febre Lassa/epidemiologia , Doença Relacionada a Viagens , Viagem , Adolescente , Adulto , África Ocidental/epidemiologia , Idoso , História do Século XX , História do Século XXI , Humanos , Febre Lassa/história , Febre Lassa/transmissão , Febre Lassa/virologia , Pessoa de Meia-Idade , Vigilância em Saúde Pública , Fatores de Risco , Estações do Ano , Adulto JovemRESUMO
We describe a strain of Lassa virus representing a putative new lineage that was isolated from a cluster of human infections with an epidemiologic link to Togo. This finding extends the known range of Lassa virus to Togo.
